ArticlePolymers2026
Synergistic Effects of Nitrosamine-Safe Accelerators for Enhanced Natural Rubber Latex Balloon in Sulfur Conventional Vulcanizing System.
Article in Polymers, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The vulcanization of natural rubber latex (NRL) relies on accelerators to achieve effective crosslinking by a sulfur conventional vulcanizing system and desirable properties such as tensile strength and elasticity. This study investigates the synergistic effects of carcinogenic nitrosamine-safe accelerators to develop a high-performance and safe NRL vulcanization system. A synergistic combination of 0.36 phr Zinc dibutyldithiocarbamate (ZBEC), 0.36 phr Tetrabenzylthiuram disulfide (TBzTD), and a trace amount of Zinc diethyldithiocarbamate (ZDEC), 0.03 phr, demonstrated optimal performance, yielding superior tensile strength (22.13 MPa), elongation at break (1153%), and thermal stability (Tmax 384.15 °C). Notably, this formulation exhibited below the detectable level limits of hazardous nitrosamines (
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.